Skip to main content
. 2021 Nov 2;4(11):e2132540. doi: 10.1001/jamanetworkopen.2021.32540

Figure 1. Effectiveness of the Ad26.COV2.S Vaccine and Comparison of COVID-19 Severity Between Vaccinated and Unvaccinated Patients.

Figure 1.

A, Real-world evidence supporting the effectiveness of the Ad26.COV2.S (J&J) COVID-19 vaccine. B, Comparison of COVID-19 severity between vaccinated and unvaccinated patients. J&J indicates Johnson & Johnson; PCR, polymerase chain reaction.